The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...
Pharmaceuticals giant GlaxoSmithKline (GSK) has lifted its long-term sales guidance as it hailed a strong drugs pipeline. It came as the boss of the London-listed firm cheered an “excellent ...
But compare GSK with UK rival AstraZeneca, which has a goal of $80bn in total revenue by 2030. Even before AstraZeneca’s forecast-beating results on Thursday, consensus for 2030 revenue was just ...
Pharmaceuticals giant GlaxoSmithKline (GSK.L) (GSK) has lifted its long-term sales guidance as it hailed a strong drugs pipeline. It came as the boss of the London-listed firm cheered an “excellent” ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results